Oncology
5,780 studies504 in 7 days2,684 in 30 days
Filters
Latest
5,780 studies
- Patient-derived IgG Amplifies Fcγ Receptor-Dependent Colonic Inflammation During Immune Checkpoint Blockade
- Quantifying Cancer Clinical Trial Eligibility Using Artificial Intelligence-Based Matching
- Navigating the cancer trajectory in colorectal cancer: perceptions of cure over care, efficiency, and limited emotional support
- Hepatic urea cycle suppression drives brown fat thermogenesis to counter obesity and liver disease
- Modular engineered colorectal tumor microenvironments for immuno-oncology research and drug development
- Liver transplantation changes the rules for colorectal liver metastases
- Rediscovering neuroblastoma pathology from the perspective of digital pathology and AI: Current challenges and future implications.
- The IL-1β signaling axis as a prognostic determinant in early-stage breast cancer: integrated analysis of tumor and circulating biomarkers.
- Reproductive factors and lung cancer risk in never-smoking women: a prospective cohort study
- Epstein–Barr Virus Common and Rare complications in Iraq: Review Paper
- Evaluation of serum miR-21, miR-29, miR-92, miR-135, miR-210, and miR-1290 biomarkers for diagnosis of colorectal cancer using systematic review and meta-analysis study
- Investigation of ferroptosis-related gene expression and oxidative stress markers in end-stage diabetic kidney disease: A case–control analysis
- Breastfeeding shapes a unique tumor-immune landscape in pregnancy-associated breast cancer from GEICAM-EMBARCAM study
- Outcomes in KEYNOTE-355 after chemotherapy discontinuation before pembrolizumab discontinuation and with immune-mediated adverse events
- ACSS2-mediated metabolic-epigenetic crosstalk drives Fulvestrant resistance and represents a novel therapeutic target
- Clinical factors are more strongly associated with prognosis than genetic alterations in early-onset colorectal cancer: a retrospective cohort study
- GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinoma
- OncoGen.AI: an integrated platform for automated genomic analysis and reporting in precision oncology
- AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
- Adjuvant Nivolumab vs Observation in Resected Non–Small Cell Lung Cancer
- Plasma signals of lung tumor promotion for molecular cancer prevention
- Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study
- The NF ‐ κB Signalling Pathway: Mechanisms, Consequences and Therapeutic Targets
- An Itch Receptor Drives Melanoma
- Ploidy shapes gemcitabine response through altered potency and delayed cell death